In this study, we explored the expression of MMP‐7, ‐8, ‐9, beta‐catenin, E‐cadherin in the ECM and ameloblastoma tumor cells and evaluated the role of those markers combined with clinical factors in predicting recurrence of ameloblastoma. This evidence concerns the gene CTNNB1 and ameloblastoma.